Curaleaf Holdings (CURLF) Operating Expenses (2019 - 2026)

Curaleaf Holdings (CURLF) posted quarterly Operating Expenses of $156.5 million for Q1 2026, up 7.07% year-on-year from $146.2 million in Q1 2025, and up 2.15% on a QoQ basis from $153.2 million in Q4 2025.

Curaleaf Holdings (CURLF) Operating Expenses (2019 - 2026) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Operating Expenses for 8 consecutive years, with $156.5 million the latest figure, recorded in Q1 2026.

  • Quarterly Operating Expenses rose 7.07% year-over-year to $156.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $614.8 million (changed 0.12% YoY) and the FY2025 annual result came in at $605.6 million, down 1.7% from the prior year.
  • Operating Expenses improved to $156.5 million in Q1 2026 per CURLF's latest filing, from $153.2 million in the prior quarter.
  • Over the last five years, Operating Expenses for CURLF reached as high as $142.2 billion in Q4 2023 and fell as low as $134.8 million in Q3 2023.
  • A 5-year average of $8.5 billion and a median of $151.3 million in 2024 frame the typical range for Operating Expenses.
  • Annual changes were most pronounced in 2023 — Operating Expenses soared 88994.43% — and 2024, when it plunged 99.88%.
  • Year by year, Operating Expenses stood at $159.6 million in 2022, then surged by 88994.43% to $142.2 billion in 2023, then tumbled by 99.88% to $163.6 million in 2024, then slipped by 6.34% to $153.2 million in 2025, then rose by 2.15% to $156.5 million in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods registered $156.5 million, $153.2 million, and $155.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.00 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 788.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 12.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 455.70 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.24 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 621.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 494.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn 156.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 156.54 Mn
Dec 31, 2025 153.25 Mn
Sep 30, 2025 155.71 Mn
Jun 30, 2025 149.27 Mn
Mar 31, 2025 146.20 Mn
Dec 31, 2024 163.63 Mn
Sep 30, 2024 151.29 Mn
Jun 30, 2024 152.92 Mn
Mar 31, 2024 148.20 Mn
Dec 31, 2023 142.23 Bn
Sep 30, 2023 134.84 Mn
Jun 30, 2023 152.04 Mn
Mar 31, 2023 142.46 Mn
Dec 31, 2022 159.63 Mn
Sep 30, 2022 135.18 Mn
Jun 30, 2022 143.90 Mn
Mar 31, 2022 135.31 Mn
Dec 31, 2021 136.24 Mn
Sep 30, 2021 140.35 Mn
Jun 30, 2021 130.22 Mn